50% off Premium Yearly

TSE:FTT
This summary was created by AI, based on 5 opinions in the last 12 months.
Finning International (FTT-T) has garnered mixed reviews from experts regarding its current valuation and performance outlook. As the largest Caterpillar dealer, it has seen a significant price movement, particularly reaching heights of $78. However, some analysts express skepticism about the stock's future, suggesting that it has outstripped its fair market value. The cyclical nature of the business adds to the uncertainty, especially amidst concerns about infrastructure and energy developments in Canada. Despite the stabilization and growth potential in equipment dealerships, many experts recommend waiting for a better entry point. Overall, while the market may be in a phase that supports industrials, the high valuation poses risks for investors at this stage.
The structural backdrop includes a lot of spending on construction and on US manufacturing facilities. Much better supply/demand for energy and materials than we've had in a decade. These are all customers of FTT.
If you look at the performance of CAT, FTT and TIH over the last year, all look very attractive. TIH does more construction, whereas FTT does more materials and so he'd lean more toward that one.
Industrials aren't too topical right now. Stock's been in a range for a couple of years, which is usually a positive sign. He'd be comfortable buying in the range, or if it spent more time above $36. Like tipping a Coke machine, sometimes it needs a couple of heaves to get it up through the price level.
50% of revenues are in western Canada, plus Chile and the UK. Higher commodity prices offer this some momentum and pushed FTT to new highs this year. But this is a cyclical name, so careful. Yesterday, CAT shares fell on shrinking demand, so that's a canary in the coalmine for FTT. Profits are decent and so is the PE. Take profits,
She'd rather own CAT, which she's been looking at. Go to the company that makes the machinery, rather than to the distributor.